Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ.

J Immunol. 2018 Jul 25. pii: ji1800271. doi: 10.4049/jimmunol.1800271. [Epub ahead of print]

PMID:
30045970
2.

Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.

Burchill MA, Roby JA, Crochet N, Wind-Rotolo M, Stone AE, Edwards MG, Dran RJ, Kriss MS, Gale M Jr, Rosen HR.

PLoS One. 2017 Oct 17;12(10):e0186213. doi: 10.1371/journal.pone.0186213. eCollection 2017.

3.

Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner.

White JT, Cross EW, Burchill MA, Danhorn T, McCarter MD, Rosen HR, O'Connor B, Kedl RM.

Nat Commun. 2016 Apr 21;7:11291. doi: 10.1038/ncomms11291.

4.

Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.

Burchill MA, Golden-Mason L, Wind-Rotolo M, Rosen HR.

J Viral Hepat. 2015 Dec;22(12):983-91. doi: 10.1111/jvh.12465. Epub 2015 Oct 7.

PMID:
26482547
5.

T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.

Burchill MA, Tamburini BA, Kedl RM.

Eur J Immunol. 2015 Nov;45(11):3140-9. doi: 10.1002/eji.201545749. Epub 2015 Aug 3.

6.

Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection.

Tamburini BA, Burchill MA, Kedl RM.

Nat Commun. 2014 Jun 6;5:3989. doi: 10.1038/ncomms4989.

7.

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.

McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1122-31. doi: 10.1073/pnas.1300392110. Epub 2013 Feb 27.

8.

T cell vaccinology: exploring the known unknowns.

Burchill MA, Tamburini BA, Pennock ND, White JT, Kurche JS, Kedl RM.

Vaccine. 2013 Jan 2;31(2):297-305. doi: 10.1016/j.vaccine.2012.10.096. Epub 2012 Nov 6. Review.

9.

TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.

Oh JZ, Kurche JS, Burchill MA, Kedl RM.

Blood. 2011 Sep 15;118(11):3028-38. doi: 10.1182/blood-2011-04-348839. Epub 2011 Aug 2.

10.

Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.

Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, Kedl RM.

J Immunol. 2010 Aug 15;185(4):2106-15. doi: 10.4049/jimmunol.1000172. Epub 2010 Jul 16.

11.

IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.

Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA.

J Immunol. 2008 Sep 1;181(5):3285-90.

12.

Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.

Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW, Vegoe AL, Hsieh CS, Jenkins MK, Farrar MA.

Immunity. 2008 Jan;28(1):112-21. doi: 10.1016/j.immuni.2007.11.022.

13.

Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.

Burchill MA, Yang J, Vang KB, Farrar MA.

Immunol Lett. 2007 Nov 30;114(1):1-8. Epub 2007 Sep 14. Review.

14.

IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA.

J Immunol. 2007 Jan 1;178(1):280-90.

15.

Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis.

Taylor DK, Walsh PT, LaRosa DF, Zhang J, Burchill MA, Farrar MA, Turka LA.

J Immunol. 2006 Aug 15;177(4):2216-23.

16.

Attenuation of IL-7 receptor signaling is not required for allelic exclusion.

Will WM, Aaker JD, Burchill MA, Harmon IR, O'Neil JJ, Goetz CA, Hippen KL, Farrar MA.

J Immunol. 2006 Mar 15;176(6):3350-5.

17.

Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.

Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Johanns TM, Farrar MA.

J Immunol. 2005 Jun 15;174(12):7753-63.

18.
19.

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, Thompson CB, Burchill MA, Farrar MA, Turka LA.

J Immunol. 2004 May 1;172(9):5287-96.

20.

STAT5 activation underlies IL7 receptor-dependent B cell development.

Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Farrar MA.

J Immunol. 2004 Apr 15;172(8):4770-8.

21.

Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.

Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, Turka LA, Brennan P, Jameson SC, Farrar MA.

J Immunol. 2003 Dec 1;171(11):5853-64.

22.

Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.

Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF.

Infect Immun. 2003 Jun;71(6):3437-42.

Supplemental Content

Loading ...
Support Center